The environmental dependence of the structure of outer galactic discs in STAGES spiral galaxies

We present an analysis of V-band radial surface brightness profiles for spiral galaxies from the field and cluster environments using Hubble Space Telescope/Advanced Camera for Surveys imaging and data from the Space Telescope A901/2 Galaxy Evolution Survey (STAGES). We use a large sample of ~330 face-on to intermediately inclined spiral galaxies and assess the effect of the galaxy environment on the azimuthally averaged radial surface brightness mu profiles for each galaxy in the outer stellar disc (24 < mu < 26.5 mag per sq arcsec). For galaxies with a purely exponential outer disc (~50 per cent), we determine the significance of an environmental dependence on the outer disc scalelength h_out. For galaxies with a broken exponential in their outer disc, either down-bending (truncation, ~10 per cent) or up-bending (anti-truncation, ~40 per cent), we measure the strength T (outer-to-inner scalelength ratio, log_10(h_out/h_in) of the mu breaks and determine the significance of an environmental dependence on break strength T. Surprisingly, we find no evidence to suggest any such environmental dependence on either outer disc scalelength h_out or break strength T, implying that the galaxy environment is not affecting the stellar distribution in the outer stellar disc. We also find that for galaxies with small effective radii (r_e < 3 kpc) there is a lack of outer disc truncations in both the field and cluster environments. Our results suggest that the stellar distribution in the outer disc of spiral galaxies is not significantly affected by the galaxy environment.Comment: Accepted to MNRAS. Appendix A available at http://www.nottingham.ac.uk/~ppxdtm/STAGES_profiles_appendix.pd

Factors influencing elderly women's mammography screening decisions: implications for counseling

<p>Abstract</p> <p>Background</p> <p>Although guidelines recommend that clinicians consider life expectancy before screening older women for breast cancer, many older women with limited life expectancies are screened. We aimed to identify factors important to mammography screening decisions among women aged 80 and older compared to women aged 65–79.</p> <p>Methods</p> <p>Telephone surveys of 107 women aged 80+ and 93 women aged 65–79 randomly selected from one academic primary care practice who were able to communicate in English (60% response rate). The survey addressed the following factors in regards to older women's mammography screening decisions: perceived importance of a history of breast disease, family history of breast cancer, doctor's recommendations, habit, reassurance, previous experience, mailed reminder cards, family/friend's recommendations or experience with breast cancer, age, health, and media. The survey also assessed older women's preferred role in decision making around mammography screening.</p> <p>Results</p> <p>Of the 200 women, 65.5% were non-Hispanic white and 82.8% were in good to excellent health. Most (81.3%) had undergone mammography in the past 2 years. Regardless of age, older women ranked doctor's recommendations as the most important factor influencing their decision to get screened. Habit and reassurance were the next two highly ranked factors influencing older women to get screened. Among women who did not get screened, women aged 80 and older ranked age and doctor's counseling as the most influential factors and women aged 65–79 ranked a previous negative experience with mammography as the most important factor. There were no significant differences in preferred role in decision-making around mammography screening by age, however, most women in both age groups preferred to make the final decision on their own (46.6% of women aged 80+ and 50.5% of women aged 65–79).</p> <p>Conclusion</p> <p>While a doctor's recommendation is the most important factor influencing elderly women's mammography screening decisions, habit and reassurance also strongly influence decision-making. Interventions aimed at improving clinician counseling about mammography, which include discussions around habit and reassurance, may result in better decision-making.</p

Measures of Galaxy Environment - I. What is "Environment"?

The influence of a galaxy's environment on its evolution has been studied and compared extensively in the literature, although differing techniques are often used to define environment. Most methods fall into two broad groups: those that use nearest neighbours to probe the underlying density field and those that use fixed apertures. The differences between the two inhibit a clean comparison between analyses and leave open the possibility that, even with the same data, different properties are actually being measured. In this work we apply twenty published environment definitions to a common mock galaxy catalogue constrained to look like the local Universe. We find that nearest neighbour-based measures best probe the internal densities of high-mass haloes, while at low masses the inter-halo separation dominates and acts to smooth out local density variations. The resulting correlation also shows that nearest neighbour galaxy environment is largely independent of dark matter halo mass. Conversely, aperture-based methods that probe super-halo scales accurately identify high-density regions corresponding to high mass haloes. Both methods show how galaxies in dense environments tend to be redder, with the exception of the largest apertures, but these are the strongest at recovering the background dark matter environment. We also warn against using photometric redshifts to define environment in all but the densest regions. When considering environment there are two regimes: the 'local environment' internal to a halo best measured with nearest neighbour and 'large-scale environment' external to a halo best measured with apertures. This leads to the conclusion that there is no universal environment measure and the most suitable method depends on the scale being probed.Comment: 14 pages, 9 figures, 1 table, published in MNRA

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Cultivating a Culture of Project Management

Presented at the DLF Forum on Tuesday, October 28, 2014 at 10:45 a.m. at the Georgia Tech Hotel and Conference Center.Cristela Garcia-Spitz is the Project Manager of the Digital Library Development Program at the University of California, San Diego Library.Carolyn Caizzi is the Assistant Department Head of Digital Collections at Northwestern University Library.Ann Caldwell is the Head of Imaging and Metadata Services in the Digital Technologies Department of the Brown University Library.Angelina Zaytsev is the HathiTrust Project Librarian at the University of Michigan Library.Cynthia York is a Project Manager in the Digital Research and Curation Center at Johns Hopkins University's Sheridan Libraries.Delphine Khanna is the Head of Digital Library Initiatives at the Samuel L. Paley Library at Temple University.Meghan Musolff is the Special Projects Librarian for Library Information Technology at the University of Michigan Library.Runtime: 77:43 minutesThe DLF Project Managers Group presents a panel of speakers who are interested in cultivating a culture of project management. Meghan Musolff and Angelina Zaytsev will discuss how the University of Michigan is attempting to develop this culture by creating positions entirely devoted to project management, as well as the creation of an informal skill sharing program open to all Library staff. Attendees will walk away with a framework and the tools to implement similar programs at their own institutions. Delphine Khanna from Temple University will address the broader question of how to manage developers’ schedules and how to communicate with administrators realistically about assigning staff resources. She will present the model being developed at Temple to tackle issues such as institution-wide project prioritization, how to handle shifting priorities, and how to maximize the developers’ job satisfaction and throughput in a systematic manner. Ann Caldwell from Brown University will discuss how with the implementation of agile project methodology has made planning easier and created a more comfortable environment for staff to take ownership of their work. Cynthia York from Johns Hopkins University will discuss the role of communication channels in agile project management. She will discuss how the use of various tools enhance communication among distributed team members, and the result of efforts to identify overlap which had led to gaps in communication. This diverse panel is designed to provide a space to highlight trends and issues in the broad discipline of library technology project management

Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.

OBJECTIVES: The aim of this study was to determine the economic impact of several anticoagulation strategies for moderate- and high-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients managed invasively. BACKGROUND: The ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial demonstrated that bivalirudin monotherapy yields similar rates of ischemic complications and less bleeding than regimens incorporating glycoprotein IIb/IIIa receptor inhibitors (GPI) for moderate- and high-risk NSTE-ACS. METHODS: In ACUITY, 7,851 U.S. patients were randomized to: 1) heparin (unfractionated or enoxaparin) + GPI; 2) bivalirudin + GPI; or 3) bivalirudin monotherapy. Patients assigned to GPI were also randomized to upstream GPI before catheterization or selective GPI only with percutaneous coronary intervention. Resource use data were collected prospectively through 30-day follow-up. Costs were estimated with standard methods including resource-based accounting, hospital billing data, and the Medicare fee schedule. RESULTS: At 30 days, ischemic events were similar for all groups. Major bleeding was reduced with bivalirudin monotherapy compared with heparin + GPI or bivalirudin + GPI (p \u3c 0.001). Length of stay was lowest with bivalirudin monotherapy or bivalirudin + catheterization laboratory GPI (p = 0.02). Despite higher drug costs, aggregate hospital stay costs were lowest with bivalirudin monotherapy (mean difference range: $184 to$1,081, p \u3c 0.001 for overall comparison) and at 30 days (mean difference range: $123 to$938, p = 0.005). Regression modeling demonstrated that hospital savings were primarily due to less major and minor bleeding with bivalirudin ($8,658/event and$2,282/event, respectively). CONCLUSIONS: Among U.S. patients in the ACUITY trial, bivalirudin monotherapy compared with heparin + GPI resulted in similar protection from ischemic events, reduced bleeding, and shorter length of stay. Despite higher drug costs, aggregate hospital and 30-day costs were lowest with bivalirudin monotherapy. Thus bivalirudin monotherapy seems to be an economically attractive alternative to heparin + GPI for patients with moderate- and high-risk NSTE-ACS. (Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes [ACS]; NCT00093158)